Healthcare Industry Mergers & Acquisitions (M&A) Outlook - Executive Summary Report
• The global Healthcare M&A market value stood at $338.6 Bn in 2020. The COVID-19 pandemic has pushed the world in an economic recession that far worse than the financial crisis in 2008–09. Although many economies have been able to sail through the economic uncertainties, the fatigue induced by the pandemic is creating a new set of problems for governments across the globe.
• While the roll-out of vaccines by multiple governments is expected to propel financial recovery, the sudden spurt in COVID-19 cases across the globe, along with the emergence of new virus strains, will likely weigh on the pace of global economic recovery.
• According to the Word Bank, the global economy is likely to shrink by 4.3% in 2020 but will likely rebound to growth of ~4% in 2021. The path to recovery is projected to be "fragile” with “formidable challenges” for policy makers.
• The pandemic showcased the resiliency of the healthcare industry owing to its ‘defensive’ nature. However, after H1 2020, with the opening up of most economies, the broader market and a majority of the heavily beaten down industries witnessed higher investor confidence on the presumption of ‘normalization’.
• Within the healthcare industry, biotech and healthcare equipment outperformed others due to the urgent need for a vaccine and innovative care delivery in new or alternative settings.
"Download the report, to gain deeper insights on the last 10 years M&A deals by volume and value, sector/segments deals information, impact of covid-19 on market consolidation and Q1 2021 M&A deals".